18/06/2026
Advancing myopia control through science and technology.
Recent clinical trial findings presented at ARVO 2026 continue to demonstrate the potential of innovative approaches to myopia management.
At HOYA Vision Care, research and evidence remain at the heart of our commitment to supporting Eye Care Professionals and improving outcomes for children with myopia.
Because innovation matters when it comes to protecting future vision.
Read our press release here | https://www.hoyavision.com/about-hoya/hoya-vision-care-news/news/arvo-miyosmart-iq-12-month-clinical-evidence-hoya-vision-care-press-release/